<p>詹姆斯哈迪工业（ASX:JHX）在最近的财报未能达到投资者预期后，股价下跌超过 13%。该公司的业绩引发了对未来需求和建筑材料业务前景的质疑。</p>
<p>查看我们对詹姆斯哈迪工业的最新分析。</p>
<p>最近的财报失利加剧了詹姆斯哈迪工业的急剧下滑，过去一个月股价下跌近 24%，年初至今股价大幅下跌 49%。势头显然减弱，1 年期的股东总回报率现在为负 54%。这突显了尽管公司在行业内长期处于领先地位，但仍面临严峻的环境。</p>
<p>如果建筑材料行业的动荡让你思考接下来该如何，或许现在是拓宽搜索范围、发现高内部持股的快速增长股票的最佳时机。</p>
<p>由于股价远低于分析师的目标价，并且估值模型显示出大幅折扣，最大的问题是市场的悲观情绪是否已经过度，还是进一步的挑战已经反映在价格中。这可能是一个买入机会，还是仍需谨慎？</p>
<h2>最受欢迎的叙述：低估 30.9%</h2>
<p>当前的叙述表明，詹姆斯哈迪工业的交易价格显著低于其估计的公允价值，估值显示其价值明显高于最后的收盘价。这一差距是由于对在收购 Azek 后显著收入和利润扩张的预期所驱动。</p>
<blockquote>
<p><em>最近收购和整合 AZEK 使詹姆斯哈迪的可服务市场翻了一番，并将其产品范围扩展到高增长的户外生活类别。这一举措为未来几年在北美持续的收入增长和双位数的收入增长奠定了基础。</em></p>
</blockquote>
<p>阅读完整叙述。</p>
<p>好奇是什么推动了这种看涨的前景？一个改变游戏规则的增长假设为整个公允价值计算定下了基调，但这并不是大多数投资者所预期的。如果你想看到推动这一叙述价格目标的硬数据和大胆预测，千万不要错过这些头条估值背后的完整故事。</p>
<p><strong>结果：公允价值为 36.82 美元（低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，美国住房需求的持续疲软和 Azek 收购带来的整合挑战可能会威胁到詹姆斯哈迪工业的乐观增长故事。</p>
<p>了解詹姆斯哈迪工业叙述的关键风险。</p>
<h2>另一种观点：基于收益倍数的估值</h2>
<p>从市盈率的角度看，詹姆斯哈迪工业的股票交易在 29 倍收益，几乎是全球行业平均水平 15.1 倍的两倍，并且高于其公允比率 27.1 倍。虽然其估值比直接竞争对手更具吸引力，但这一溢价表明如果增长放缓，存在实质性的估值风险。市场是否在定价过于乐观？</p>
<p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/495dd61b-435f-47cc-85eb-6d1cd108c1b5/chart/pe-multiple-vs-industry?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/495dd61b-435f-47cc-85eb-6d1cd108c1b5/chart/pe-multiple-vs-industry"/></p>
<p>ASX:JHX 截至 2025 年 11 月的市盈率</p>
<h2>自建詹姆斯哈迪工业叙述</h2>
<p>如果你想从不同的角度看，或者想自己深入数字，你可以在几分钟内自建詹姆斯哈迪工业的叙述。按照你的方式进行。</p>
<p>进行詹姆斯哈迪工业研究的一个很好的起点是我们的分析，突出了 3 个关键收益和 4 个可能影响你投资决策的重要警示信号。</p>
<h2>寻找更多投资想法？</h2>
<p>聪明的投资者知道，最佳机会只需轻轻一击。通过探索这些精心挑选的选项，提升你的投资组合：</p>
<ul>
<li>通过查看这 18 只收益率超过 3% 的股息股票，发现收入潜力，这些股票提供有吸引力的收益和可靠的支付，适合长期增长和稳定。</li>
<li>当你研究这 31 只医疗保健 AI 股票时，抓住医疗技术的增长浪潮，这些股票将 AI 突破与现实世界的医疗创新结合在一起。</li>
<li>通过寻找这 3577 只财务状况良好的便士股票，追逐波动性并追求超额收益。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不意图作为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

<p>詹姆斯·哈迪工业（ASX:JHX）股价在令人失望的财报发布后下跌超过 13%，引发了对未来需求和建筑材料业务前景的担忧。该股票在一个月内下跌近 24%，年初至今下跌 49%。尽管目前被低估 30.9%，但美国住房需求疲软和 Azek 收购整合问题等挑战依然存在。该股票的市盈率为 29 倍，高于行业平均水平，表明如果增长放缓，存在估值风险。建议投资者考虑其他投资机会</p>

<p>James Hardie Industries (ASX:JHX) shares have dropped more than 13% after a recent earnings report missed investor expectations. The company’s results have sparked questions about future demand and the outlook for its building materials business.</p>
<div class="lb-trans"><p>詹姆斯哈迪工业（ASX:JHX）在最近的财报未能达到投资者预期后，股价下跌超过 13%。该公司的业绩引发了对未来需求和建筑材料业务前景的质疑。</p>
</div><p>See our latest analysis for James Hardie Industries.</p>
<div class="lb-trans"><p>查看我们对詹姆斯哈迪工业的最新分析。</p>
</div><p>The recent earnings stumble has added to a sharp slide for James Hardie Industries, with the share price down nearly 24% over the past month and a steep 49% share price decline year-to-date. Momentum has clearly faded, and the 1-year total shareholder return now sits at negative 54%. This underscores the tough environment facing the company despite its longer-term industry leadership.</p>
<div class="lb-trans"><p>最近的财报失利加剧了詹姆斯哈迪工业的急剧下滑，过去一个月股价下跌近 24%，年初至今股价大幅下跌 49%。势头显然减弱，1 年期的股东总回报率现在为负 54%。这突显了尽管公司在行业内长期处于领先地位，但仍面临严峻的环境。</p>
</div><p>If the building materials shakeup has you thinking about what’s next, now could be the perfect moment to broaden your search and discover fast growing stocks with high insider ownership</p>
<div class="lb-trans"><p>如果建筑材料行业的动荡让你思考接下来该如何，或许现在是拓宽搜索范围、发现高内部持股的快速增长股票的最佳时机。</p>
</div><p>With shares trading well below analyst price targets and steep discounts suggested by valuation models, the big question is whether market pessimism has gone too far, or if further challenges are already reflected in the price. Could this be a buy, or is caution still warranted?</p>
<div class="lb-trans"><p>由于股价远低于分析师的目标价，并且估值模型显示出大幅折扣，最大的问题是市场的悲观情绪是否已经过度，还是进一步的挑战已经反映在价格中。这可能是一个买入机会，还是仍需谨慎？</p>
</div><h2>Most Popular Narrative: 30.9% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：低估 30.9%</h2>
</div><p>The prevailing narrative suggests that James Hardie Industries is trading at a significant discount to its estimated fair value, with valuations putting its worth notably higher than the last closing price. This gap is driven by expectations of substantial revenue and margin expansion following the Azek acquisition.</p>
<div class="lb-trans"><p>当前的叙述表明，詹姆斯哈迪工业的交易价格显著低于其估计的公允价值，估值显示其价值明显高于最后的收盘价。这一差距是由于对在收购 Azek 后显著收入和利润扩张的预期所驱动。</p>
</div><blockquote>
<p><em>The recent acquisition and integration of AZEK has more than doubled James Hardie's addressable market and expanded its product offering into high-growth outdoor living categories. This move sets the stage for sustained top-line acceleration and double-digit revenue growth across North America over the coming years.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>最近收购和整合 AZEK 使詹姆斯哈迪的可服务市场翻了一番，并将其产品范围扩展到高增长的户外生活类别。这一举措为未来几年在北美持续的收入增长和双位数的收入增长奠定了基础。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Curious what powers this bullish outlook? One game-changing growth assumption sets the tone for the entire fair value calculation, but it is not what most investors expect. If you want to see the hard numbers and bold projections driving this narrative’s price target, do not miss the full story behind these headline valuations.</p>
<div class="lb-trans"><p>好奇是什么推动了这种看涨的前景？一个改变游戏规则的增长假设为整个公允价值计算定下了基调，但这并不是大多数投资者所预期的。如果你想看到推动这一叙述价格目标的硬数据和大胆预测，千万不要错过这些头条估值背后的完整故事。</p>
</div><p><strong>Result: Fair Value of $36.82 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 36.82 美元（低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, persistent softness in US housing demand and integration challenges from the Azek acquisition could threaten the optimistic growth story for James Hardie Industries.</p>
<div class="lb-trans"><p>然而，美国住房需求的持续疲软和 Azek 收购带来的整合挑战可能会威胁到詹姆斯哈迪工业的乐观增长故事。</p>
</div><p>Find out about the key risks to this James Hardie Industries narrative.</p>
<div class="lb-trans"><p>了解詹姆斯哈迪工业叙述的关键风险。</p>
</div><h2>Another View: Valuation by Earnings Multiple</h2>
<div class="lb-trans"><h2>另一种观点：基于收益倍数的估值</h2>
</div><p>Looking at James Hardie Industries through the lens of its price-to-earnings ratio, the shares trade at 29x earnings, which is nearly double the global industry average of 15.1x and above its fair ratio of 27.1x. While it is valued more attractively than direct peers, this premium signals material valuation risk if growth wavers. Could the market be pricing in too much optimism?</p>
<div class="lb-trans"><p>从市盈率的角度看，詹姆斯哈迪工业的股票交易在 29 倍收益，几乎是全球行业平均水平 15.1 倍的两倍，并且高于其公允比率 27.1 倍。虽然其估值比直接竞争对手更具吸引力，但这一溢价表明如果增长放缓，存在实质性的估值风险。市场是否在定价过于乐观？</p>
</div><p>See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/495dd61b-435f-47cc-85eb-6d1cd108c1b5/chart/pe-multiple-vs-industry" alt="" original-src="https://images.simplywall.st/company/495dd61b-435f-47cc-85eb-6d1cd108c1b5/chart/pe-multiple-vs-industry"/></p>
<p>ASX:JHX PE Ratio as at Nov 2025</p>
<div class="lb-trans"><p>ASX:JHX 截至 2025 年 11 月的市盈率</p>
</div><h2>Build Your Own James Hardie Industries Narrative</h2>
<div class="lb-trans"><h2>自建詹姆斯哈迪工业叙述</h2>
</div><p>If you want a different angle or want to dig into the numbers yourself, you can build your own James Hardie Industries narrative in just a few minutes. Do it your way.</p>
<div class="lb-trans"><p>如果你想从不同的角度看，或者想自己深入数字，你可以在几分钟内自建詹姆斯哈迪工业的叙述。按照你的方式进行。</p>
</div><p>A great starting point for your James Hardie Industries research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.</p>
<div class="lb-trans"><p>进行詹姆斯哈迪工业研究的一个很好的起点是我们的分析，突出了 3 个关键收益和 4 个可能影响你投资决策的重要警示信号。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Smart investors know that the best opportunities are just a click away. Level up your portfolio by exploring new companies and trends with these handpicked options:</p>
<div class="lb-trans"><p>聪明的投资者知道，最佳机会只需轻轻一击。通过探索这些精心挑选的选项，提升你的投资组合：</p>
</div><ul>
<li>Uncover income potential by checking out these 18 dividend stocks with yields &gt; 3%, offering attractive yields and reliable payouts for long-term growth and stability.</li>
<li>Catch the growth wave in healthcare technology when you examine these 31 healthcare AI stocks, which blend AI breakthroughs with real-world medical innovation.</li>
<li>Ride the volatility and chase outsized gains by finding these 3577 penny stocks with strong financials that boast strong financials and stand out from the crowd.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过查看这 18 只收益率超过 3% 的股息股票，发现收入潜力，这些股票提供有吸引力的收益和可靠的支付，适合长期增长和稳定。</li>
<li>当你研究这 31 只医疗保健 AI 股票时，抓住医疗技术的增长浪潮，这些股票将 AI 突破与现实世界的医疗创新结合在一起。</li>
<li>通过寻找这 3577 只财务状况良好的便士股票，追逐波动性并追求超额收益。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不意图作为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

James Hardie (ASX:JHX)：在收益不及预期且股价下跌后评估其估值